Corticosteroid Injections and Adenovirus Vector-Based COVID-19 Vaccines

Our newest IPSIS FactFinder provides guidance on the timing of elective corticosteroid injections around Johnson & Johnson and AstraZeneca COVID-19 vaccines. For these adenovirus vector-based vaccines, IPSIS recommends timing injections no less than two weeks prior to and no less than two weeks following vaccine administration, when possible. Because patient-specific factors certainly vary, IPSIS unequivocally emphasizes the importance of risk/benefit analyses and shared decision-making when weighing the timing of epidural and intraarticular corticosteroid injections in patients receiving COVID-19 vaccinations.

Download this latest free IPSIS FactFinder to delve deeper. Interested in earning CME while reviewing the evidence? Visit the online learning platform, and for a nominal fee you can review the FactFinder and complete a post-test to earn 0.5 AMA PRA Category 1 Credit(s)™.

Questions about timing of corticosteroid injections and mRNA vaccines? Review the IPSIS FactFinder on Pfizer-BioNTech and Moderna mRNA vaccines.

IPSIS reviews, updates, and shares information on the COVID-19 pandemic on an ongoing basis. For the most up-to-date guidance and links to additional resources, bookmark the SIS COVID-19 page and click on the social media icons above to follow and share.

Help sustain these vital efforts with your donations.The International Pain and Spine Intervention Society (IPSIS) is a tax exempt organization under US section 501(c)(3) of the Internal Revenue Code. As such, contributions are deductible to the extent allowed by law.